Surgical Incision Closure Market Growth, Share And Forecasts 2014 To 2020

Surgical incision closure market is expected to register significant growth over the forecast period owing to increasing investment in research and development, reduced level of trauma along with reducing risks of infection, and increasing demand to shorten length of hospital stay. Appropriate incision closure during surgery is crucial to maintain integrity of tissues and regain normal functions. Primary objective during a surgery is to achieve hemostasis and to seal the incision both internally and externally. Any failure to seal the incisions perfectly leads to severe medical conditions such as infection and critical scarring. Introduction of technologically advanced incision closure products is additionally expected to propel growth of this market.

Surgical incision and closure market is segmented on three different bases such as type, application and products. On the basis of type market is divided into advanced wound care market and advanced wound closure market. Burns, ulcers and surgical wounds are the market types based on application. Sutures, tissue sealants and staplers are the three types on the basis of products. Sutures possess one of the highest market share and are expected to continue the dominance owing to the expansive product development efforts. For instance, recently developed barbed suture technology is designed to face challenging procedures such as endoscopic surgeries. Tissue sealants on the other hand is gaining market share steadily. Their demand is specially rising in case of cosmetic and minimally invasive surgeries. Surgical staplers continue to generate majority of sales. They have applications in many gynecologic, thoracic, and pediatric procedures but bariatric and emphysema market accounts for major share.

North America is expected to have the largest share due to higher consumer base of aesthetic surgeries, spinal fusion, and rising numbers of hip and knee replacement surgeries. Asia Pacific is expected to register a lucrative growth owing to improvement in healthcare infrastructure, rising spending in healthcare segment, new establishments of healthcare & diagnostic centers, and increased access to healthcare services.

Major players of the market are BTG plc, Cryolife, 3M healthcare, Ethicon, Covidien Plc., Smith and Nephew, Baxter International, Genzyme Biosurgery, Axya medical, Henkel Loctite Corporation and Tyco healthcare.

Request for toc of this report at:

http://www.grandviewresearch.com/industry-analysis/surgical-incision-closure-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Healthcare Analytics Market Revenue To Near $42.8 Billion By 2024:Grand View Research, Inc.

The global healthcare analytics (HA) market is expected to reach USD 42.8 billion by 2024, according to a new report by Grand View Research, Inc. Efforts to reduce the spiraling healthcare costs is facilitating the usage of the healthcare analytics. Additionally, the benefits of HA include the improvement of patient access to customized care, the furthering of transparent operations to enable better public oversight, and innovation in patient care delivery and services.

                                      Predictive Analytics market estimates and trends

Furthermore, analytics play a major part in striving to ameliorate the health economic efficiency. For instance, l’Assurance Maladie in France employed analytics to assess the clinical safety of the class of cholesterol-lowering drugs, statins, which have been implicated in causing severe side-effects, and the derived results were used to introduce evidence-based performance measures to address the cracks in the operational system.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market

Further key findings from the study suggest:

• Descriptive analytics held a significant share in 2015 owing to its applications in process optimization in organizations. On the other hand, predictive analytics is anticipated to grow at a lucrative rate over the forecast period mainly due to its wide applicability in medical systems, such as fraud prevention, disease prevalence forecasts, and risk assessment.

• The services category dominated the component segment in 2015. Outsourcing of these big data services contributed towards their growth in leading to the high volume of services rendered. Moreover, the outsourcing of services helps in cutting costs associated with infrastructure requirements and in addition, avoids the requirement of skilled individuals to perform the same task.

• The hardware systems category dominated the component segment, high-cost of the hardware, such as the use of computer systems and internet servers contributed to its growth.

• On-premise delivered analytic services dominated the delivery mode category with around 54.0% share in 2015. However, the cloud-based delivery mode segment is anticipated to grow at a profitable rate over the forecast period. The benefits of the cloud system, which include remote data entry and real-time data entry features are expected to result in the growth of this segment.

• The applications of the healthcare big data include financial applications, operational & administrative applications, and clinical applications. Operational and administrative applications governed the applications segment and held a remunerative share in the year, 2015.

• The demand for financial applications is anticipated to boost over the forecast period. These applications include payment and claim settlements and fraud prevention and risk analysis. Various initiatives undertaken by the government, such as the Fraud Prevention System (FPS) from the CMS is promoting its adoption.

• The end-users of HA include payers, providers, and others. Payers held a significant market share in 2015 and the providers are anticipated to grow at a lucrative rate. The usage of these services by providers is for population health management, quality improvement, and personalized care.

• North America captured a significant share in the global market. Advanced healthcare infrastructure in this region and the growing per capita healthcare expenditure supported the greater consumption of these services.

• The Asia Pacific region is expected to witness gainful growth attributable to the untapped opportunities in the countries including India and China.

• Some key players operating in the healthcare analytics market include IBM Corporation, Oracle Corporation, SAS, Cerner Corporation, Allscripts Healthcare Solutions, Inc., Optum Health, Inc., and Verisk Analytics, Inc. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments directed towards R&D efforts.

• For instance, in December 2015 Truven Health Analytics, Inc. and Philips Electronics N.V. integrated Truven Health Micromedex Solutions in the management platform, the Tasy System. This integrated platform is anticipated to facilitate fast and easy access to a wealth of evidence-based medical information present in the drug interaction repositories of Micromedex Solutions.

Grand View Research has segmented the global healthcare analytics market on the basis of products, end-use, and region:

Global Healthcare Analytics Market by Type, 2013 - 2024 (USD Million)

• Descriptive Analytics

• Predictive Analytics

• Prescriptive Analytics

Global Healthcare Analytics Market by Component, 2013 - 2024 (USD Million)

• Software

• Hardware

• Services

Global Healthcare Analytics Market, by Delivery Mode, 2013 - 2024 (USD Million)

• On-premise

• Web-based

• Cloud-based

Global Healthcare Analytics Market, by Application, 2013 - 2024 (USD Million)

• Clinical

• Financial

• Operational and Administrative

Global Healthcare Analytics Market, by End-use, 2013 - 2024 (USD Million)

• Healthcare Payers

• Healthcare Providers

• Others

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/healthcare-analytics-market/request

Laboratory filtration market is expected to reach USD 3.6 billion by 2024, according to a new report by Grand View Research, Inc.

The laboratory filtration market is expected to reach USD 3.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing number of target diseases such as water-borne diseases, immunodeficiency diseases, and cancer is anticipated to boost the market growth. The increasing use of filtration technologies such as microfiltration, nanofiltration, and ultrafiltration in water purification plants is expected to enhance growth in this sector.

                                  U.S. Laboratory Filtration Market by Product, 2013 - 2024 (USD Million)

Technological advancements in filtration products have resulted in an increase in the adoption rate of these products in clinical laboratories for research purposes. The products introduced provide benefits such high reliability, competency, and high throughput over the conventional methods. For instance, Merck Millipores millex syringe filters filter small-volume filtrates and these filters are ideally used for antibiotics and tissue culture additives.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market

Further Key Findings From the Study Suggest:

• The filtration media segment dominated this market in 2015, with a revenue share of over 40%.The large share is attributed to its cost-effective nature, higher efficiency, and reliability for industrial bioprocessing.

• Microfiltration assemblies dominated the assembly segment in 2015. Some of the benefits associated with microfilters such as easier availability, portability, and easier disposal make them the highly preferred technology.

• The microfiltration technology segment held the largest share in 2015, owing to the increasing application of microfiltration in industrial biotechnology and associated research.

• North America dominated the overall market with a revenue share of over 42% in 2015, owing to the presence of well-equipped laboratories for life science research, increasing investments in R&D, and the presence of government funding programs for laboratory filter membrane business owners.

• Asia Pacific is anticipated to be the fastest growing region with a CAGR of over 8.3%in the forecast period.Factors such as economic development, untapped market opportunities, new emerging market, and advancing healthcare system with the aid of supportive government initiatives are anticipated to assist in growth.

• The presence of major market players enhances the penetration of laboratory filtration product in the market. Some of the key players are Merck Millipore, Sigma-Aldrich, GE Healthcare, Thermo Fisher Scientific, Sartorius Group, 3M Company, Cantel Medical Corporation, Macherey-Nagel Gmbh& Co. Kg.

• The key players are entering into collaborations such as mergers and acquisitions with other key players to increase their market share. For instance, in November 2015, Merck Millipore acquired Sigma-Aldrich to enhance its life science segment, and this business segment based in the U.S. is named as MilliporeSigma.

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/laboratory-filtration-market/request

Patient Portal Market Growth, Share And Segment Forecasts to 2024

The global patient portal market is expected to reach USD 5.2 billion by 2024, according to a new report by Grand View Research, Inc. The demand for Electronic Health Record (EHR) with a patient portal is expected to exhibit an upsurge over the forecast period, owing to the increasing demand, favorable government funding policies, and the continual technological advancements offered by the key industrial players. 

In May 2016, CureMD signed a pledge of Voluntary National Interoperability. This pledge stated that action plans to develop and implement rapid flow in healthcare information between providers, patients, and other concerned authorities are to be implemented. 

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/patient-portal-market

Further Key Findings From the Report Suggest: 

• Integrated Patient portal was identified as the most lucrative segment in 2015. The rapid shift of providers from their previous methods to the EHRs, advancements in technology, and increasing demand were some of the reasons for its largest market share. 

• In June 2015, ICON (a global drug development and service provider) launched its online “Firecrest Patient Portal” It was specifically designed for a person to understand the entire treatment process before consulting the provider and view information regarding clinical trials. 

• Moreover, this provided services such as online appointment registration, laboratory tests and reports, and other necessary facilities. 

• Also, as per a report by the European commission, 11regions across the European Union (EU) had participated in the “Sustains project” since 2012, which was EU sponsored. This project was an initiative for joint learning, providing patients’ access to their health records and other online services. 

• North America dominated the market in 2015 as a result of the technological advancements and implementation of healthcare IT in the region. 

• In June 2014, Brattleboro Memorial Hospital launched “myHealthPortal.” It is expected to provide easy and early access to the selected portions of the health records. It is safe and secure, providing confidential communication between the providers and the patient. 

• Europe is expected to grow at a higher rate over the forecast period due to increasing demand of efficient healthcare delivery and advanced solutions. Increased government initiatives in the region and deployment of EHR-based portal solutions are considered responsible for its high growth rate. 

• In November 2015, an event was organized in the European Parliament by members of the European Parliament, Health Policy Partnership, Lung Cancer Europe, and European Cancer Patient’s Coalition. This event witnessed the launch of an Immuno-oncology Patient Portal that proved to be a unique solution for people suffering from cancer in Europe. 

• Developers are collaborating and expanding with the aim of combining the use of innovation and technology to improve efficiency and provide better services for the convenience of the providers. 

• In 2016, McKesson Corporation announced a partnership with Blue Cross Blue Shield of Arizona. This partnership will help deliver a broad range of services, thereby assisting the service providers. 

• In 2015, GE Healthcare announced the acquisition of Camden Group in order to provide their clients access to analytics that involves change management and activation resources, which support organizational and clinical changes. 

• Some key players in this market are GE Healthcare, Allscripts Healthcare Solutions, McKesson Corporation, and Cerner Corporation. 

Grand View Research has segmented the global patient portal market on the basis of type, deployment mode, end use, and regions: 

Patient Portal Type Outlook (Revenue, USD Million, 2013 – 2024)

• Standalone Patient Portal

• Integrated Patient Portal

Patient Portal Deployment Mode Outlook (Revenue, USD Million, 2013 – 2024)

• Web-Based Delivery

• Cloud-Based Delivery

Patient Portal End-Use Outlook (Revenue, USD Million, 2013 – 2024)

• Providers

• Players

• Pharmacies

• Others

To get full details at:

http://www.grandviewresearch.com/industry-analysis/patient-portal-market/request

Single Cell Analysis Market To Be Driven By Increasing Demand In healthcare scenario - Grand View Research

The global Single Cell analysis market is expected to reach USD 5.0 billion by 2024, according to a new report published by Grand View Research, Inc. The rising adoption of Single Cell analysis tools owing to the improving healthcare scenario is fueling the growth of the market.

The continuous efforts in the R&D sector of the healthcare industry are resulting in the wide applicability of the Single Cell analysis technologies in the different disease areas, as a widespread diagnostic tool to address the complex heterogeneity observed in cells. Introduction of stem cell therapies and non-invasive techniques for prenatal analysis are some of the examples of the applications of the Single Cell analysis techniques. On the contrary, the high-cost and long shelf-life of the instruments is challenging the growth of the market.

                      China Single Cell Analysis Market, by Instrument type, 2014 - 2024 (USD Million)

In addition, the increasing pool of individuals suffering from target diseases, such as cancer, and neurological disorders, rising per capita income, and the government initiatives to encourage the R&D in healthcare sectors are augmenting the demand for Single Cell analysis in the developing countries. The extensive demand for non-invasive techniques for prenatal diagnosis to prevent the immunological and genetic disorders in fetuses is fueling the demand for Single Cell tests in the market. The penetration of advanced therapeutic tools for the treatment of chronic diseases, such as cancer related to the malfunctions of the Single Cells is proving to be a boon for the global market. Moreover, the adoption of stem cell therapy for treatments related to bone marrow transplants, hair regeneration, and other health-related issues is widening the scope of the Single Cell analytical technologies globally.

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa (MEA). North America accounted for the largest market share and was followed by Europe in 2015.Well-developed healthcare and R&D infrastructure and the availability of skilled labor are pushing the adoption of Single Cell analysis in these regions.

AsiaPacificis expected to show the fastest growth rate during the forecast period. Factors, such as the booming medical tourism, availability of advanced healthcare treatments, and the availability of skilled healthcare professionals at a lower cost are some of the factors anticipated to accelerate the adoption of Single Cell analysis in the Asia Pacific region. Moreover, the increasing government expenditure for clinical research activities and the improvement of healthcare infrastructure are boosting the growth of the market. As a result, the Asia Pacific market is anticipated to capture around 21% of the global share during the forecast period.

Players are implementing strategies, such as partnerships, collaborations, and mergers to expand their market share. The collaborative agreement between Illumina, Inc. and Bio-Rad Laboratories, Inc. is one such example of the strategic endeavors undertaken by the market players.

Further key findings from the study suggest:

• The consumables segment accounted for the largest market share and is expected to maintain its dominance owing to the repeat purchase of reagents, assay kits, beads, and microplates

• The instruments market segment is expected to show significant growth during the forecast period

• The applications segment of the market is further divided into cancer, neurology, immunology, prenatal diagnosis, and in-vitro fertilization. Increasing prevalence of the target diseases is propelling the growth of the market. 

• North America captured the largest market share of around 38% in 2015 and is estimated to maintain its dominance throughout the forecast period. Speedy adoption of analytical techniques and the rising R&D efforts in the field of diagnostics are the major factors contributing to the largest market share of North America in the global market. The AsiaPacific region is expected to show significant growth from 2016 to 2024 due mainly to the flourishing clinical research sector, medical tourism, and the high government healthcare expenditure in the region.

• The major market players in this market include but are not limited to Thermo Fisher Scientific, Inc., Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.)

Download free sample request at:

http://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request

Post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022

Global post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of Adverse Drug Reactions (ADRs) coupled with incorporation of advanced ADR reporting tools is responsible for the overall growth of the post-marketing pharmacovigilance and medical information market. Increased drug consumption can be attributed to rising prevalence of chronic diseases such as tuberculosis that involve multiple drug regimes.

Post-marketing pharmacovigilance penetration and future growth opportunities, bytype of reporting

Rising government initiatives for improvement of pharmacovigilance services and maintenance of medical databases are also responsible for inducing overall growth of post-marketing pharmacovigilance and medical information market. For instance, in December 2015, the USAID Systems for Improved Access to Pharmaceuticals and Services (SIAPS) launched PViMS tool to improve drug safety monitoring in low and middle income countries by helping clinicians, researchers, and regulatory authorities to collect, analyze, and monitor ADRs.

View summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market

Further key findings from the study suggest:

• Spontaneous reporting dominated the post-marketing pharmacovigilance market in terms of revenue share as of 2014 and accounted for over 30.0% of market owing to wide usage in reporting of unknown and suspected ADRs. Preference of healthcare professionals and researchers towards this method is also responsible for the overall growth of this segment. 
• Cohort event monitoring is anticipated to be the fastest growing in post-marketing pharmacovigilance owing to application in all types of clinical events. Moreover, associated benefits such as early detection, high accuracy, and cost-efficiency are also anticipated to be the growth inducing factors. 
• Books dominated the overall product segment in terms of revenue share as of 2014 owing to the preference by clinicians and healthcare professionals as a primary source of information pertaining to adverse drug reactions. Online media is anticipated to be the fastest growing segment with a CAGR of over 13.0 % during the forecast period owing to rising inclination towards digitalized data. 
• Hospitals held the dominant share of end-use segment as a consequence of low costs associated with hospital based post-marketing pharmacovigilance surveillance. Research organizations segment is anticipated to show significant growth rate in coming years owing to streamlining of R&D in developing of new medicines and improving risk management through early prognosis of ADRs. 
• The key players of post-marketing pharmacovigilance and medical information market include Accenture Plc., Clinquest Group B.V., Cognizant Technology Solutions Corporation, Covance, Inc., iMEDGlobal Corporation, inVentiv Health Clinical, Parexel International Corporation, Pharmaceutical Product Development, Inc., PRA Health Sciences, Inc., Quintiles, F. Hoffmann-La Roche Ltd., Sanofi Aventis, Synowledge LLC, Wipro Ltd., ArisGlobal, Ergomed Plc. Rising strategic alliances and mergers &acquisitions are also anticipated to drive market growth. For instance, in January 2016, strategic collaboration of Parexel and Optum for reducingcosts related to post-approval studies and spreading awareness among the population base. 

To get free sample request:
http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market/request

Increasing demand for pneumonia market share and Forecasts 2015 to 2022

Global pneumonia market is expected to witness lucrative growth as the consequence of rising number of geriatric population and increasing prevalence of lung diseases, viral infections & heart diseases, among children thereby elevating the risk of developing pneumonia. Treatment advances facilitates benefits such as better efficacy & potency and lower incidence of potential side effects which are expected to drive the demand for the market over the forecast period. These advances include advent of new drugs namely trimethoprim-sulfamethoxazole and parental pentamidine isethionate. Moreover, better drug delivery & targeting techniques such as nebulization and aerosolization of drug facilitating relative ease of administration, high attainable drug levels and low side-effects are expected to drive the market growth potential further over the forecast period.

Access full research report at:

http://www.grandviewresearch.com/industry-analysis/pneumonia-market

The global pneumonia market is segmented on the basis of treatment drugs & vaccines market and mode of acquisition. On the basis of treatment drugs and vaccines, it is further segmented into antibiotics such as cephalosporins, penicillin, fluoroquinolones, tetracyclines, amoxicillin & vancomycin wheras vaccines include PCV13 & PPV23. On the basis of mode of acquisition, it is classified into hospital acquired pneumonia, community acquired pneumonia and ventilator acquired pneumonia. As of 2014, treatment drugs segment held the largest share of pneumonia market owing to the benefits such as better drug response, fast onset of action and higher efficacy & potency. On the basis of mode of acquisition, hospital acquired pneumonia held the largest market owing to factor such as increasing multidrug resistance in microorganisms in the hospital settings.

Geographically, pneumonia market is segmented into North America, Europe, Asia Pacific, Latin America and MEA. As of 2014, North America held the largest share in the pneumonia market owing to factors such as increasing multi drug resistance by microorganisms in viral infections among children and adults. Rising geriatric population and government initiatives are also responsible to drive the demand for pneumonia market in this region. For Instance, WHO and UNICEF Integrated Global Action Plan For Pneumonia and Diarrhoea (GAPPD) aims to accelerate pneumonia control with a combination of interventions to protect, prevent, and treat pneumonia in children and availability of advanced healthcare systems. Additionally, high awareness and disposable income are potential contributors to the growth of this market over the forecast period. Asia Pacific region is anticipated to be the fastest growing market due to prominent growth factors such as rising accessibility, increasing patient awareness, improving healthcare infrastructure and incremental disposable income.

The major players of the pneumonia market include Sanofi, AstraZeneca, GlaxoSmithCline, Eli Lilly, Merck & Co., Pfizer, Novartis and Baxter International Inc. These companies focus on crucial strategies such as development of innovative diagnostic systems, targeting developing regions and providing services aimed at better patient information & quality of life with better view for market penetration.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/pneumonia-market/request-toc

Pulmonary Drug Delivery Systems Market Share, Analysis and Forecasts 2015 to 2022

Global pulmonary drug delivery systems market is anticipated to exhibit a lucrative market over the forecast period owing as a consequence of rising prevalence of chronic diseases such as tuberculosis, diabetes mellitus and chronic obstructive pulmonary disease which require more rigorous treatment. Limitations pertaining to traditional treatments including low efficacy and late onset of action are expected to induce the need of developing targeted drug delivery systems, thereby driving the demand for the market over the next seven years. Technological advancements such as particle engineering, agglomerated vesicle technology, incorporation of MDI technology, supercritical fluid technology are expected to boost the market growth further. These advancements, which include minimizing unwanted toxicities, improved stability with drugs, increased bioavailability of drugs, no degradation of drug and localized drug deposition, are expected to facilitate the demand for the market. Furthermore, other benefits associated with pulmonary drug delivery systems such as rapid treatment of local respiratory disorders, better penetrability of drug, minimum dosage requirement, targeted therapy, higher patient safety and avoidance of gastrointestinal problems are anticipated to propel the market growth potential over the forecast period.

Access full research report at:

http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market

The global pulmonary drug delivery systems market is categorized on the basis of product and application. On the basis of product it is segmented into metered dose inhalers, nebulizers and dry powder inhalers. Nebulizers are further segmented into jet nebulizers, ultrasonic nebulizers and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). As of 2014, nebulizers followed by metered dose inhalers held the substantial share of the pulmonary drug delivery systems market due to direct application of drugs to the airways for the treatment of respiratory diseases such as asthma & COPD. Treatment advances such as usage of enantiomer preparations of inhaled drugs leading to better efficacy also played a significant role in the overall growth of this segment. Dry powder inhalers are expected to be the fastest growing segment owing to factors such as advancements in formulating technology facilitating treatment in outpatient settings. Furthermore, applications of computational fluid dynamics such as airflow changes anddeagglomeration in this segment result in better design & development of DPI devices are also expected to induce demand for this segment over the forecast period.

Geographically, the pulmonary drug delivery system market is segmented into North America, Europe, Asia Pacific, Latin America and MEA. As of 2014, North America held substantial share owing to prominent growth factors including increasing incidences of pulmonary disorders such as bronchitis, rising prevalence of geriatric population, advanced healthcare infrastructure, vast lifestyle associated changes and high disposable income. Additionally, government initiatives and increasing health awareness in this region is also responsible for the growth of pulmonary drug delivery systems market. Furthermore, the rising number of mergers & acquisitions between pharmaceutical companies and technology providers and increased demand for self-administration & outpatient healthcare devices boosted the market in this region. Asia Pacific region is expected to be the fastest growing market as a consequence of contributing factors such as improving healthcare infrastructure, rising disposable income and increasing patient awareness levels. Furthermore, new market players leading to increasing competition is anticipated to play a significant role in providing growth potential to the pulmonary drug delivery systems market in this region over the forecast period.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market/request-toc

Vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.

                                          Vein Illuminator Market, by End-user, 2013 - 2024 (USD Million)

The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Further key findings from the study suggest:

• In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.

• The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.

• The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.

• The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system.

Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application:

Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024)

• Transillumination

•  Infrared technology

• Others

Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024)

• Intravenous access

• Blood draw

• Others

Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024)

• Hospitals

• Blood donation camps

• Academic institutions

• Others

Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America

• Europe

• Asia Pacific

• Latin America

• MEA

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market/request

Electronics health records (EHR) market size was estimated USD 19.96 billion in 2014 and the market is expected to grow at a CAGR of 5.2% over the forecast period

Global electronics health records (EHR) market size was estimated USD 19.96 billion in 2014 and the market is expected to grow at a CAGR of 5.2% over the forecast period. Quality improvements of healthcare services owing to the implementation of advanced technology tools, rising importance of granting the patients access to critical medical information, and improving their safety concerns are few of the driving factors for the significant increase in the electronic health records market.

                          North America EHR market revenue by product, 2012 - 2022, (USD Million)

Global EHR market is anticipated to value worth USD 29.81 billion by 2020.Electronic health records are a consolidated report storing a wide range of information like the laboratory test results, demographics, diagnostic images, medical history of patients and medications provided. Their ability to provide up-to date and accurate patient information, reduced medical errors, increased patient participation, reduced healthcare cost and improved efficiency are major factors driving the EHR market demand. 

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market

Increased usage of tablets and smartphones has augmented the EHR market demand as well. Patient records could be easily managed with reduced human errors by implementing the EHR software to record the medical history of patients giving traceability and ease operation. Favourable government policies like the American Recovery and Reinvestment Act (ARRA) is expected to support the growth of EHR market. 

On the basis of product, the EHR market is segmented into web or cloud-based and client-server based. Web-based EHR market has accounted the largest product segment and accounts for over USD 16.00 billion in 2014. Client-server based EHR systems mostly store in-house data. They need hardware, software and a server to be installed. 

Cloud-based EHR have the advantage over client server based systems as they store information on external servers and web access is possible via a platform and a web service. Web based EHR market is expected to significantly grow at a CAGR of 5% owing to the lucrative benefits of ease of interoperability, no cost of maintenance of licensing and little investments in infrastructure.

On the basis of end use and application, market subsegments of EHR market are hospital use and ambulatory use. However, the ambulatory sub segment is further sub-segmented into stand-alone facility, clinical use and retail pharmacy use. As of 2014, hospital use shared the largest revenue due to increasing need for medication & consulting, optimum services and growing competition. Ambulatory use is the next largest segment anticipated to grow at a considerable rate due to diagnostics labs & clinics, usage of wireless EHR in retail pharmacies,and rising demand for EHR mobile operations. 

As of 2014, North America accounted for the largest share over USD 9.5 billion and a government law providing USD 64,000 from Medicare and Medicaid to every medical practitioner adopting EHR systems. Rising demand for improved quality of medical services, increased pressure for healthcare cost containment, and encouragement through government funding are some of the major factors for North America electronic health record market growth. 

In 2014, Europe also shared profit in terms of revenue owing to the various development activities by prominent players of the EHR market. An Epic system was installed at Cambridge University Hospitals NHS Foundation Trust, in the UK, costing USD 214 million, in October 2014. 

Emerging economies like India, China, Mexico, Brazil and South Africa are expected to demonstrate high economic growth and reflect immense potential for EHR market especially due to rising health awareness among the rising population and increasing disposable income. 

Significant players in the EHR market are Siemens Medical Solutions,GE Healthcare, MEDITECH, McKesson Corp., and NextGen Healthcare.

To get free sample request:

http://www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market/request

Computational Biology Market is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research

The Global Computational Biology Market is expected to reach USD 4,285.1 million by 2020 growing at a CAGR of 21.1%, according to a new study by Grand View Research, Inc. Steady increase in the usage & application of computational biology for bioinformatics R&D programs designed for sequencing genomes to better understand biological systems and increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug discovery studies are expected to drive computational biology demand over the next six years.

Computational genomics for cellular and biological simulation applications dominated the market in 2013, accounting for over 47% of global revenue. Key factors driving demand for these applications include the growth of drug designing, disease modeling and personalized medicine applications and the growing usage of computational biology for functional and structural genomics, epigenomics and metagenomics for the analysis of protein transcription, protein-protein interactions, gene sequencing and expression and 3-dimensional protein structure analysis.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the study suggest:

• North America was the largest regional market, accounting for 58.0% of the global revenue in 2013. Its large share is majorly attributed to the growing research investments and initiatives for development of drug discovery, disease modeling technologies and innovations in biological computation methods. It is expected that Asia Pacific will witness the fastest growth in the market, at an estimated CAGR of 28.0% owing to the increasing expenditure in clinical studies for pharmacokinetics and pharmacogenomics.
• The application of computational biology in proteomics for cellular simulation is expected to grow at the fastest CAGR of over 22% owing to the shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of development of personalized medicine.
• Drug discovery and disease modelling applications dominated the market, accounting for 58.0% of global revenue in 2013. This large share is attributed by the extensive drug development pipelines present for a number of global branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli Lilly.
• Computational Biology databases dominated the tools segment and accounted for 44.5% of the market revenue in 2013, owing to extensive genomic database usage for warehousing and data mining of biological and sequential data generated from genomic and proteomic studies. Consequentially, the software and services for the analysis of biological data is expected to witness the fastest CAGR of over 21.0%.
• Key players of this market include Schrodinger, Accelrys, Certara, Entelos, Simulation Plus and others.

Download free sample request at:

http://www.grandviewresearch.com/industry-analysis/computational-biology-market/request

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Hospital asset management market is expected to witness a lucrative growth during the forecast period owing to the increasing issues in supply chain management along with increasing incidences of drug counterfeiting

Hospital asset management market is expected to witness a lucrative growth during the forecast period owing to the increasing issues in supply chain management along with increasing incidences of drug counterfeiting. Growing acceptance of asset management techniques due to reduction in cost of software, hardware are expected to drive this market through to 2022. Introduction of technological advancements such as Zigbee, smart active labels (SAL) are also expected to fuel market demand. Improvements such as near field communication have made asset management increasingly efficient and cost effective. Furthermore, rising privacy concern in hospital and healthcare organization, increasing use of hospital and pharmaceutical industry for effective supply chain and advantages such as increased return on investment and cost savings are expected to boost the growth of hospital asset management in the next seven years.

Hospital asset management market is segmented on the basis of pharmaceutical & healthcare products and applications. The healthcare products offered in the market are Wi-Fi based real time location systems (RTLS), radio frequency identification (RFID), infrared and ultrasound tags. Radio frequency identification segment in the asset management market accounted for largest market share in 2014 owing to its technological up gradation from locating patients, assets and error prevention of drugs to drug anti-counterfeiting, theft prevention, drug trial compliance and cost control as well as increasing healthcare applications such as tracing and tracking of consumable medicines, visitor alarm and locating staff and accurate & speedy location of assets. However, Wi-Fi based real time location systems (RTLS) in the healthcare segment is expected to witness a significant growth in demand in the next seven years due to increasing adoption of RTLS as a result of its increasing application in healthcare sector and declining cost of hardware. The pharmaceutical product available in the market is radio frequency identification technology (RTLS). Radio frequency identification technology (RTLS) tags both in pharmaceuticals and healthcare and is expected to play a prominent role in the growth of hospital asset management market due to its increasing demand and applications for efficient work flow. On the basis of applications, hospital asset management market is divided into humidity control, staff management, patient management, and temperature & equipment management. Asset management in pharmaceutical vertical finds application such as supply chain and drug counterfeiting. Increasing number of complex equipments in modern day hospitals require highly specialized and efficient asset management systems and increasing investment by government and private organizations in implementing RFID technology as organizations such as World Health organization and FDA suggested the use RFID in enhancing the quality of supply chain in order to eliminate the fake drugs in the global market    are factors which are expected to drive the demand for hospital asset management through to the 2022.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/hospital-asset-management-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Our blog: http://www.grandviewresearch.com/blogs

Structural Biology and Molecular Modeling Technique Market Growth, Competitive Strategies and Forecasts, 2015 To 2022

Global structural biology and molecular modeling technique market is expected to witness lucrative growth owing to the collaborative efforts focusing on R&D activities and recent advancements in the field of biology. The market is forecasted to witness significant growth as a consequence of novel opportunities in the field of computational biology and sociology in drug discovery processes with computer assisted softwares.

Advances in drug discovery and development process such as the development of innovative computational techniques in modeling biological processes of disease, is expected to serve as a high impact rendering driver for the growth of the industry. These techniques substantially reduce the cost for drug discovery processes, by widening the scope for viable targets and by identifying novel therapeutic strategies for drug development, which is expected to boost the usage rates of these techniques.

Increasing number of computer assisted procedures in structural biology which supports integrative model; serve the market with significant growth opportunities during the forecast period.

Technological advancement with the assistance of sophisticated molecular modeling softwares, accounts for the most promising areas in medicinal research activities. In addition, growing adoption rate amongst researcher professionals to analyze protein homology and dock libraries of these biomolecules is anticipated to positively reinforce market growth over the forecast period.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market/request-toc

With extensive use of computer assisted molecular modeling techniques, have acquired notable development in the discovery of HIV protease inhibitors to curb with the effect of HIV infection and AIDS.

Advances in the field of X-ray crystallography for superior quality imaging to analyze the atomic structures, are expected to drive the market growth. Recent developments that focus on chemical design with modified softwares are aimed at accelerating drug discoveries in pharmaceutical organizations.

Increasing number of funding by government in pharmaceutical industries and research organizations addressing the issues of molecular elements and biomarker development, are expected to propel the market growth.

Global structural biology and molecular modeling technique market is segmented on the basis of application and software types. Application segment is further segmented as computational chemistry, biotechnology, bioinformatics (that includes drug design), computational biology and material science.

Bioinformatics was one of the largest application areas included in the study. Constant developments in the field of Chemoinformatics with successful prediction methods and growing acceptance of this technique in wide applications areas are among the key rendering driver for the growth of the market.

Software types include chime, web lab viewer, chem draw, chimera, swiss pdb viewer, visual molecular dynamics and spartan. Improvements pertaining to modify these softwares in an array of applications for calculation of various parameters that include ab-initio molecular orbital, semi empirical molecular orbital and ADMET properties for drug discovery processes.

Emerging trends in developing sophisticated softwares that serve as integrated environment with latest modules for performing all modeling operations in molecular biology and chemistry are expected to facilitate the market growth.

Visit our blog: http://www.grandviewresearch.com/blogs/healthcare

Medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand. 

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors.

                    North America medical sensors market share, by product, 2013-2024 (USD Million)

The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes. The presence of a large target population base combined with the prevalence of lifestyle-related risk factors is likely to accelerate the growth of the medical sensors market during the forecast period. 

Technological advancements in terms of accuracy, portability, and affordability associated with the new generation medical sensors resulted in the increased usage of these devices; for instance, the introduction of easy-to-operate, home-based diagnostic kits that are cost effective.  

Access full market research report at: 

http://www.grandviewresearch.com/industry-analysis/medical-sensors-market

Further key findings from the study suggest: 

• The biosensors products segment held a lucrative share of over 40.0% in 2015. This is ascribable to the following attributes of the novel biosensors: durability, reliability, and accuracy. Moreover, their applications in the healthcare areas, such as the detection of drug abuse, glucose monitoring for diabetes, the detection of cholesterol, and others. All these elements governed the growth of this segment in 2015. 

• The surgical applications of the sensors dominated the market in 2015. Whereas, the monitoring applications segment is projected to be the fastest growing during the forecast period. Advancements, such as wearable technology are anticipated to boost the demand for the monitoring devices market. 

• The hospitals registered a remunerative growth in 2015; this can be attributed to the presence of a well-developed healthcare infrastructure, which yields faster and accurate diagnosis. Moreover, the availability of well-equipped infrastructure coupled with the presence of skilled personnel and technologically advanced equipments contribute towards the lucrative growth of this segment. 

• North America held a considerably large share of over 35.0% in 2015 owing to the presence of leading sensor manufacturers, a well-planned medical reimbursement network, and the increasing disposable income 

• On the contrary, Asia Pacific is anticipated to be the fastest growing region with a CAGR of over8.0% over the forecast period. The favorable economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to further assist the growth. Moreover, the increasing base of the aging population in this region also, additionally impels the demand. According to the report published by the Ministry of Statistics, in India, 8.6% of the total population is aged above 60; hence, presenting a profitable opportunity for the market players to invest in this region. 

• The leading players of the medical sensors market include Analog devices, Inc., Avago technologies Ltd., Danaher Corporation, GE Measurement &Control Solutions, Inc., Honeywell International, Inc., Stellar technologies, Inc., OmniVision Technologies, Inc., Sensation AG, TE Connectivity Ltd., Micro-Epsilon Messtechnik GmbH Co. & KG, and NXP Semiconductors N.V. 

Free sample request at:

http://www.grandviewresearch.com/industry-analysis/medical-sensors-market/request

Medical suction devices market is expected to grow swiftly owing to the increasing prevalence of chronic respiratory diseases, such as asthma, and lung cancer

The global medical suction devices market is expected to reach USD 1.04 billion by 2024, according to a new report by Grand View Research. The global medical suction devices market is expected to grow swiftly owing to the increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary diseases, asthma, and lung cancer. Additionally, the market is growing rapidly due mainly to the increasing adoption of suction pumps in the point-of-care facilities. Moreover, the availability of compact suction devices has fostered the usage of these devices in ambulatory and emergency centers.
                                 Medical Suction Devices Market, by Region, 2014 - 2024 (USD Million)

The government bodies including Ministry of Health and Family Welfare (MOHFW), Central Drugs Standard Control Organization (CDSCO), and Association of Indian Medical Device Industry (AIMED) provide the medical devices sector with a regulatory structure to promote indigenous production. Such regulations are positively impacting the market. Moreover, the increasing number of collaborations undertaken by companies, such as Drive Medical, Olympus Corporation, Laerdal Medical, with the aim of introducing technologically-advanced and improved devices is further boosting the growth of the market.

However, the lack of reimbursement coverage for the homecare suction devices and the high-cost of the wall-mounted devices are some of the factors impeding the growth of the market.

Some of the key players in this market include Allied Healthcare Products, Inc., Precision Medical, Inc., Drive Medical, INTEGRA Biosciences AG, Medicop, Inc., SSCOR, Inc., ATMOS MedizinTechnik GmbH & Co. KG, ZOLL Medical Corporation, Welch Vacuum, Laerdal Medical, Labconco Corporation, Amsino International Inc., and Olympus Corporation.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/medical-suction-devices-market

Further key findings from the study suggest:

• The non-portable segment is anticipated witness lucrative growth during the forecast period owing to the increasing number of surgical procedures and the high price of the devices. As a result, this segment is projected to grow at the highest CAGR from 2016 to 2024.

• The upsurge in the number of hospitals, clinics, and other healthcare facilities is propelling the demand for non-portable aspiration devices

• The electrically powered vacuum systems segment captured the largest market share in 2015.The large market share of the segment was attributed to the widespread awareness and adoption of these devices in surgical settings.

• The portable segment is expected to show rapid growth during the forecast period owing to the rising adoption of home healthcare services where portable and user-friendly medical devices are in demand

• North America captured the largest market share of around 30% in 2015. Some factors contributing to the dominance of the segment include the presence of well-established healthcare infrastructure, existence of the leading market players, and the easily attainable approval for the class I devices by the U.S. Food and Drug Administration (FDA)

• Asia Pacific is identified as the fastest growing market for medical suction devices. The factors including a large number of untapped customers, the growing trends in the adoption of the technically-advanced devices, and the expected rise in the target patient population are anticipated to drive the growth of the market.

Grand View Research has segmented the medical suction devices market on the basis of portability, vacuum systems, end-use, and geography.

Medical Suction Devices Market, by Portability, 2013 - 2024 (USD Million)

• Portable

• Non-portable

Medical Suction Devices Market, by Vacuum Systems, 2013 - 2024 (USD Million)

• Manual

• Electrically powered

• Venturi

Medical Suction Devices Market, by End-use, 2013 - 2024 (USD Million)

• Respiratory

• Gastric

• Wound suction

• Delivery room

• Others

To get free sample request at:

http://www.grandviewresearch.com/industry-analysis/medical-suction-devices-market/request

Rising prevalence of chronic diseases due to togavirus is the major factor driving the rubella diagnostic testing market

Rising prevalence of chronic diseases due to togavirus is the major factor driving the rubella diagnostic testing market. Increasing incidences of rubella is a direct consequence of high transmission ability of togavirus via air. Rubella infection generally affects children and adults. The infection has serious implications in pregnant women, which can lead to fetal death or congenital defects. Increasing demand for MMR vaccines for the protection of children against rubella and introduction of advance point of care diagnostic technologies such as BioPlex 2200 MMRV (varicella zoster, rubella, mumps and measles virus) by Bio Rad Laboratories are  additionally propelling the growth of global rubella diagnostic testing market. In a probe to combat rubella disease, various  government initiatives  pertaining to research and development of advanced diagnostic techniques in emerging countries such as China and India are carried  out, which is  in turn expected to propel growth of market in near future. However, there is no typical drug therapy available for treatment of rubella in present, which is expected to restrain the growth of rubella diagnostic testing market over the forecast period.

The overall rubella diagnostic testing market is categorized on the basis of diagnostic testing techniques into flow cytometry, latex slide agglutination test, monoclonal antibodies, immunoassays, serological testing and clinical evaluation. These tests are  typically prescribed for pregnant women  along with  women planning to conceive and health professionals who are in contact with pregnant women. These tests may also be performed for babies born with congenital defects.

Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA. As of 2014, Europe was one of the largest market in terms of revenue  share owing to the increased cases of rubella infection in this region. According to the Pan American Health Organization (PAHO) and WHO, Colombia and Latin America are declared free of rubella infection, as of 2011. However, epidemics of rubella are still present in developing regions such as Africa and South East Asia. Vaccination for rubella are not available in these regions. Thailand, Timor Leste, Macedonia, Tajikistan and Syria are accounted for largest number of rubella infection cases as of 2013. Asia Pacific region is expected to register lucrative growth over the forecast period owing to larger untapped opportunities, increasing government initiatives for development of novel vaccines and therapies and compartively lower cost of production.

The global rubella diagnostic testing market is highly fragmented due to the engagement of various established as well as emerging players in the market. Some key players operating in the market include Ortho Clinical Diagnostics, Merck & Co., Siemens AG, GlaxoSmithKline plc., Hoffmann La Roche Ltd., Bio Rad Laboratories, Inc., BioMerieux SA, Beckman Coulter Inc. and Abbott Laboratories. These companies are constantly involved in R&D for gaining competitive advantage in the global market.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/rubella-diagnostic-testing-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Clinical Diagnostics Market Analysis, Competitive Strategies And Forecasts 2015 To 2022

Development of sophisticated and specialized tests for early disease detection and disease management and increasing demand for lab automation are the key drivers of clinical diagnostics market. The rapidly rising use of point of care diagnostic products has introduced a decentralization trend in the healthcare industry. Patients and healthcare facilities in an attempt to encourage early diagnosis, to cater medical facilities remotely and curb costs are now decentralizing their facilities. A wide array of clinical tests facilitate healthcare specialists the ability to detect disease progression which also include blood and urine test ranging from simple to complex, molecular expression genetic analysis and various medical chemistry panels. Other key factors driving the market are growing rate of chronic diseases such as diabetes, heart failure and colon cancer, increasing demand for personalized medicine expanding geriatric population base and growing patient awareness towards disease diagnosis.

The global laboratory test market is expected to grow at a lucrative rate through the forecast period. Diagnostics market is segmented into clinical laboratory testing market and point-of-care testing. There are more than 4,000 different diagnostic tests available today and have been divided into lipid panel, complete blood count, HbA1c tests, HGB/HCT, BUN creatinine, liver panel, electrolytes testing, basic and comprehensive metabolic and renal panel tests. Lipid panel test is anticipated to be the fasted growing segment due to high prevalence of obesity and cholesterol related disease. Point of care diagnostics market is expected to show a significant growth rate during the forecast period owing to the growing geriatric population base, the ability of point of care diagnostic tests to render immediate results and hence improved patient care and rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records). For instance, Troponin test is used to diagnose heart attacks in the emergency room which measures the level of troponin, a protein that distresses cardiac cells secretion into the patient’s blood stream.

Global clinical diagnostic laboratory testing market is segmented into four major regions namely North America, Europe, Asia Pacific, Latin America and MEA. North America held the largest market share in terms of revenue owing to  increasing geriatric population base, rising patient awareness towards value of laboratory tests, availability of cost effective diagnostic tests related to chronic diseases such as AIDS and hepatitis C. Growing demand for the healthcare services in emerging markets and the presence of high unmet clinical testing needs have resulted in development of lucrative opportunities for growth of laboratory testing market in emerging economies such as China and India.

Key participants operating in the clinical diagnostics testing market are Siemens Healthcare, Sonic Healthcare Ltd, Charles River Laboratories, Quest Diagnostics Inc., Bioscientia Healthcare, Bio-Reference Laboratories, ARUP Laboratories, Abbott Laboratories, Labco S.A., Healthscope Limited., and Laboratory Corporation of America Holdings (Labcorp), Qiagen, Genoptix Medical Laboratory, Genzyme Corporation and Clarient Inc.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/clinical-diagnostics-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Agricultural produce as a consequence of using organic seed treatment is also expected to attract demand for biological seed treatment market

The global biological seed treatment is expected to grow at a considerable rate throughout the forecast period owing to their inherent prefer ability over other pest control methodologies. The rising global food requirements, encouraging government policies towards microbial products and growing demand for organic and environment friendly products are some of the major drivers expected to drive demand for this market. The overall increase in quality of agricultural produce as a consequence of using organic seed treatment is also expected to attract demand for biological seed treatment market.

The primary segmentation of this market is achieved by dividing the biologically treated seeds by their crop type which segments them into oilseeds & pulses, grains & cereals, vegetables & fruits. Some of the other types of crops included in the market are forage, turf, plantation and ornamental crops. Owing to the high market demand present for grains and cereals, the largest share of the market is accounted for by this segment. A treatment type-wise segmentation of the market includes microbial treatments and botanical treatments where microbial would use bacteria and fungi among others. Owing to their better environment friendly characteristics, relative cost effectiveness as compared to fertilizers, ease in management of residue is the primary drivers for the growth of this segment over the forecast period.

Geographical segmentation of the biological seed treatment market is achieved by breaking it into North America, Europe, Asia Pacific and RoW. In 2013, the largest market was observed to be dominated by North America. Due to the presence of technologically advanced agriculture practices and high yielding farming techniques and equipments, it is expected that over the coming six years the global biological seed treatment market is going to be dominated by this region. In terms of usage rates for these treated seeds, agricultural segments of Europe are second only to North America and are expected to grow at a considerable rate through to 2020.

With h the presence of a large population base and increasing technological developments in the emerging economies of India and China, it safe to expect that the most lucrative growth of this market can be expected for the Asia Pacific region. The major participants in the biological seed treatment market are Bayer CropScience AG, Valent Biosciences Corp., Italpollina,S.p.a., Arysta LifeScience Ltd., BASF SE, Monsanto, Syngenta AG, Koppert B.V. and Novozymes.

Request for TOC of this report:

http://www.grandviewresearch.com/industry-analysis/biological-seed-treatment-market/request-toc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com